A Highly Potent and Cellularly Active β-Peptidic Inhibitor of the p53/hDM2 Interaction

被引：15

作者：

Hintersteiner, Martin ^{[1
,2
]}

Kimmerlin, Thierry ^{[2
]}

Garavel, Geraldine ^{[2
]}

Schindler, Thorsten ^{[2
]}

Bauer, Roman ^{[2
]}

Meisner, Nicole-Claudia ^{[2
]}

Seifert, Jan-Marcus ^{[2
]}

Uhl, Volker ^{[2
]}

Auer, Manfred ^{[1
,2
]}

机构：

[1] Univ Edinburgh, Ctr Translat & Chem Biol, Edinburgh EH9 3JR, Midlothian, Scotland

[2] Novartis Inst BioMed Res, Innovat Screening Technol Unit, A-1235 Vienna, Austria

来源：

CHEMBIOCHEM | 2009年 / 10卷 / 06期

关键词：

antitumor agents; beta-peptides; hDM2; inhibitors; p53; protein-protein interactions; HELICAL SECONDARY STRUCTURE; PROTEINOGENIC SIDE-CHAINS; DRUG DISCOVERY; GAMMA-PEPTIDES; DOMAIN; P53; ACIDS;

D O I：

10.1002/cbic.200800803

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

[No abstract available]

引用

页码：994 / 998

页数：5

共 50 条

[31] Cytotoxic effect of a non-peptidic small molecular inhibitor of the p53-HDM2 interaction on tumor cells [J].

Li, Wen-Dong ;

Wang, Mi-Juan ;

Ding, Fang ;

Yin, Da-Li ;

Liu, Zhi-Hua .

WORLD JOURNAL OF GASTROENTEROLOGY, 2005, 11 (19) :2927-2931

[32] N-Acylpolyamine inhibitors of HDM2 and HDMX binding to p53 [J].

Hayashi, Ryo ;

Wang, Deyun ;

Hara, Toshiaki ;

Iera, Jaclyn A. ;

Durell, Stewart R. ;

Appella, Daniel H. .

BIOORGANIC & MEDICINAL CHEMISTRY, 2009, 17 (23) :7884-7893

[33] Expression of cyclooxygenase-2 in colorectal adenocarcinoma is associated with p53 accumulation and hdm2 overexpression [J].

Cressey, R ;

Pimpa, S ;

Tontrong, W ;

Watananupong, O ;

Leartprasertsuke, N .

CANCER LETTERS, 2006, 233 (02) :232-239

[34] Cytotoxic effect of a non-peptidic small molecular inhibitor of the p53-HDM2 interaction on tumor cells [J].

Wen-Dong Li .

World Journal of Gastroenterology, 2005, (19) :2927-2931

[35] ROS and p53 in Regulation of UVB-induced HDM2 Alternative Splicing [J].

Tong, Lingying ;

Wu, Shiyong .

PHOTOCHEMISTRY AND PHOTOBIOLOGY, 2015, 91 (01) :221-224

[36] Development of a binding assay for p53/HDM2 by using homogeneous time-resolved fluorescence [J].

Kane, SA ;

Fleener, CA ;

Zhang, YS ;

Davis, LJ ;

Musselman, AL ;

Huang, PS .

ANALYTICAL BIOCHEMISTRY, 2000, 278 (01) :29-38

[37] Cyclooxygenase inhibitors modulate the p53/HDM2 pathway and enhance chemotherapy-induced apoptosis in neuroblastoma [J].

Lau, L. ;

Hansford, L. M. ;

Cheng, L. S. ;

Hang, M. ;

Baruchel, S. ;

Kaplan, D. R. ;

Irwin, M. S. .

ONCOGENE, 2007, 26 (13) :1920-1931

[38] Cyclooxygenase inhibitors modulate the p53/HDM2 pathway and enhance chemotherapy-induced apoptosis in neuroblastoma [J].

L Lau ;

L M Hansford ;

L S Cheng ;

M Hang ;

S Baruchel ;

D R Kaplan ;

M S Irwin .

Oncogene, 2007, 26 :1920-1931

[39] Reactivation of p53 function in synovial sarcoma cells by inhibition of p53-HDM2 interaction [J].

D'Arcy, Padraig ;

Ryan, Brid Ann ;

Brodin, Bertha .

CANCER LETTERS, 2009, 275 (02) :285-292

[40] A small HDM2 antagonist peptide and a USP7 inhibitor synergistically inhibit the p53-HDM2-USP7 circuit [J].

Mukherjee, Srijata ;

Saha, Gouranga ;

Roy, Neeladri Sekhar ;

Naiya, Gitashri ;

Ghosh, Mrinal K. ;

Roy, Siddhartha .

CHEMICAL BIOLOGY & DRUG DESIGN, 2023, 102 (01) :126-136

← 1 2 3 4 5 →